L’Oreal says weight loss drugs are impacting beauty and skin care sales
L'Oreal reported that the rise in weight loss drug use is affecting its beauty and skin care sales while the company designs new products to address related side effects.
Sales figures beat expectations
The company announced on Thursday that sales for the three months ending in September rose by 7.7 percent. This increase occurred above analyst expectations despite the challenging global context facing the beauty market.
New products target skin sagging
Nicolas Hieronimus stated that brands like SkinCeuticals and Kiehl's now offer products designed to complement GLP-1 side effects. These items specifically address issues such as loose skin around the face caused by rapid weight loss.
Company expands clinical aesthetic stake
L'Oreal has increased its ownership in dermatology firm Galderma to move further into the clinical aesthetic space. The use of drugs like Ozempic and Wegovy has boomed in popularity after being found to suppress appetite.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.